U.S. retail pharmacies struggling with vaccine administration as demand surges
Despite a strong supply, U.S. retail pharmarcies are, in some places, struggling to quickly administer COVID-19 vaccines, The Wall Street Journal reports.
Some Americans are facing "waits of days or weeks for doses as local health officials hustle to improve access to meet surging demand," the Journal writes, noting chains like CVS, Walgreens, and Walmart have been increasingly unable to accomodate walk-ins.
Health officials attribute the jolt in vaccine interest to recent booster eligibility for millions, newly-recommended use in children as young as five, and concerns about the new Omicron variant, per the Journal.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Demand for vaccinations is particularly high at this time so we encourage people to schedule their appointments in advance," Walgreens said. Retail pharmacies, who have provided roughly two-thirds of the country's COVID vaccinations, continue to embrace their inoculation responsibility, but are struggling with staffing, the Journal notes, causing "some locations to limit hours or close drive-throughs."
CVS said it has open slots and enough doses for the next two weeks, but in-store waits or pre-scheduled appointments may be necessary. The chain told the Journal it had recently hired thousands of pharmacists, pharmacist technicians, and other workers to help with COVID testing and vaccine administration.
Confusion over which drugstores allow walk-ins — which some Walmart pharmacies, for example, stopped offering due to overwhelming demand — is also adding to the problem, local health officials told the Journal. The White House on Thursday said the federal pharmacy partnership is working to expand availability.
"That message to just go ahead and walk in might be appealing," said Dr. Matt Willis, public health officer for Marin County, Calif., "but it doesn't work very well."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published